Evidence map›Paper›PMID 32766170›Full record

ArticleFrontiers in cellular and infection microbiology2020

The NAD

Dipak Manna, Daniela Lozano-Amado, Gretchen Ehrenkaufer, Upinder Singh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Amoebae: beyond pathogens- exploring their benefits and future potential.Frontiers in cellular and infection microbiology · 2024
    Review
  4. Review
  5. Review
  6. Giant cells: multiple cells unite to survive.Frontiers in cellular and infection microbiology · 2023
    Review
  7. Entamoeba stage conversion: progress and new insights.Current opinion in microbiology · 2020
    Review
  8. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.Frontiers in cellular and infection microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dipak MannaDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.
Daniela Lozano-AmadoDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.
Gretchen EhrenkauferDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.
Upinder SinghDivision of Infectious Diseases, Stanford University School of Medicine, Stanford, CA, United States.
Stanford University · US

Funding

Transcription factor control of Entamoeba developmentR21AI119893 · NIAID · STANFORD UNIVERSITY · PI SINGH, UPINDER · 2015 to 2016
$435k
NIAID NIH HHS R21 AI119893
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Entamoeba histolyticaHeat-Shock ResponseProtozoan ProteinsTranscription FactorsHumansNADNADProtozoan ProteinsTranscription FactorsencystationEntamoebaheat-shockmultinucleated giant cellstranscription factor

Identifiers

PMID32766170
PMCPMC7379229
OpenAlexW3043439809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.